Official title and information are available only for Plus and Premium subscribers.
Technology The offer is a new diagnostic test which may confirm the Streptococcus agalactiae infections in pregnant women. The proposed test uses a specific reaction of immunoreactive proteins derived from clinical isolates of S. agalactiae with the antibodies present in the serum of patients, and provides an alternative to commonly used solutions in this field.
To see the additional information details please login and subscribe to a Plus or Premium account.
